Icon (ICLR) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Icon (ICLR) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 25.96% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 9.08% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -12.16% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 92.39% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 32.57% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -9.98% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -129.09% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -119.28% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.39% |
| Mar 31, 2026 | -37.74% |
| Dec 31, 2025 | -11.34% |
| Sep 30, 2025 | -3.74% |
| Jun 30, 2025 | -33.12% |
| Mar 31, 2025 | -17.99% |
| Dec 31, 2024 | 62.40% |
| Sep 30, 2024 | 17.91% |
| Jun 30, 2024 | 7.21% |
| Mar 31, 2024 | 86.37% |
| Dec 31, 2023 | 840.64% |
| Sep 30, 2023 | 59.75% |
| Jun 30, 2023 | 11.99% |
| Mar 31, 2023 | -22.66% |
| Dec 31, 2022 | -120.50% |
| Sep 30, 2022 | -28.50% |
| Jun 30, 2022 | 41.75% |
| Mar 31, 2022 | 102.75% |
| Dec 31, 2021 | 48.30% |
| Sep 30, 2021 | 167.02% |